Biochemistry

B.Sc.(Hons), Imperial College of Science, Technology and Medicine, 1992-1995; Ph.D., Ecole Polytechnique Federale de Lausanne, 2003-2007; NUS Overseas Postdoctoral Fellow, Massachusetts Institute of Technology, 2007-2009.

Contact Information

Office: S15-05-01
Tel: (65)-6516-5131 | Fax: (65)-6779-1691
Email: ang.weehan@nus.edu.sg | Personal webpage

 

ORCID: 0000-0003-2027-356X
ResearcherID: L-2249-2013

 

Recognition and Achievements

 

Research Interests

We are interested in the development of therapeutic metallopharmaceuticals and techniques to investigate the interactions of transition metal-based drugs with their biological targets.

 

Research Highlight

Ref. : Ong, J. X.; Lim, C. S. Q.; Le, H. V.; Ang, W. H., A Ratiometric Fluorescent Probe for Cisplatin: Investigating the Intracellular Reduction of Platinum(IV) Prodrug Complexes. Angew. Chem. Int. Ed. 2019, 58, 164-167. A ratiometric fluorescent probe was engineered to detect the clinically-relevant platinum drug cisplatin. The ability to distinguish platinum(II) species from their parental platinum(IV) complexes allowed us to apply the probe to study the activation of platinum(IV) carboxylate prodrug complexes within a complex intracellular environment.

(a) Figure shows the Förster resonance energy transfer (FRET)-based fluorescent probe for the ratiometric sensing of cisplatin. The probe has high selectivity towards Pt2+ ion as other biologically relevant metal ions (Na+, K+, Mg2+, Cu2+, Ni2+, Zn2+, Fe2+ and Fe3+) have no significant effect on its emission profile. (b) Figure shows the application of the ratiometric probe to investigate the intracellular reduction of platinum(IV) prodrug complexes based on the cisplatin scaffold.

 

Teaching Contributions

 

Representative Publications